GlaxoSmithKline
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2005-12-22
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 130
- Registration Number
- NCT00268177
- Locations
- π¬π§
GSK Investigational Site, London, United Kingdom
Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
- Conditions
- Neoplasms, EndometrialEndometrial Cancer
- First Posted Date
- 2005-12-21
- Last Posted Date
- 2012-07-11
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 70
- Registration Number
- NCT00267488
- Locations
- ππΊ
GSK Investigational Site, Debrecen, Hungary
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
- First Posted Date
- 2005-12-14
- Last Posted Date
- 2020-11-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 80
- Registration Number
- NCT00265148
- Locations
- π¬π§
GSK Investigational Site, West End, Southampton, United Kingdom
Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy
- Conditions
- Epilepsy
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2017-10-30
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 333
- Registration Number
- NCT00264680
Long-term Study Of Paroxetine in Women and Men
- Conditions
- Social Phobia
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 50
- Registration Number
- NCT00264654
- Locations
GSK Investigational Site
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
- Conditions
- Epilepsy
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2016-09-23
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 45
- Registration Number
- NCT00264615
- Locations
- πΊπΈ
GSK Investigational Site, Richmond, Virginia, United States
GW679769 In Fibromyalgia
- Conditions
- DepressionFibromyalgiaDepressive Disorder
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 8
- Registration Number
- NCT00264628
Study In Patients With Dyslipidaemia
- Conditions
- Metabolic Syndrome X
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 290
- Registration Number
- NCT00264667
- Locations
- πͺπΈ
GSK Investigational Site, Tarrasa, Barcelona, Spain
Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.
- Conditions
- Acellular PertussisDiphtheriaTetanus
- First Posted Date
- 2005-12-09
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 321
- Registration Number
- NCT00263679
- Locations
- π©πͺ
GSK Investigational Site, Husum, Schleswig-Holstein, Germany
Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety
- Conditions
- Acellular PertussisTetanusDiphtheria
- First Posted Date
- 2005-12-09
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 401
- Registration Number
- NCT00263692
- Locations
- πΊπΈ
GSK Investigational Site, Mechanicsville, Virginia, United States